GH Research (GHRS) Cash from Operations Growth (3y) (2023 - 2025)
GH Research (GHRS) Cash from Operations Growth (3y) (2023 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Ops. Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
- |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
37.40% |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
20.11% |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
- |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
16.64% |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
- |
| 10 |
GH Research |
9.73 Bn |
9.63 Bn |
- |
-31.27% |
| Date | Value |
|---|
| Dec 31, 2025 |
-31.27% |
| Sep 30, 2025 |
-28.43% |
| Jun 30, 2025 |
-29.90% |
| Mar 31, 2025 |
-21.67% |
| Dec 31, 2024 |
-50.07% |
| Sep 30, 2024 |
-14.14% |
| Jun 30, 2024 |
-111.90% |
| Mar 31, 2024 |
-113.74% |
| Dec 31, 2023 |
-305.20% |
| Sep 30, 2023 |
-423.49% |
